NFE2L2 and bladder transitional cell carcinoma: In hepatocellular carcinoma, genomic modifications were mainly detected in the KEAP1 gene [168] and in urothelial bladder carcinoma a probable link with NRF2 and thioredoxin signaling was observed [169].